BRAF mutation in fine‐needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|10|1432-1438

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.10, 2015-10, pp. : 1432-1438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine‐needle aspiration specimens of papillary thyroid carcinoma

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 10, 2015-10 ,pp. : 786-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility of BRAF mutation detection in fine‐needle aspiration biopsy samples read as “suspicious for papillary thyroid carcinoma”

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 12, 2015-12 ,pp. : 1788-1793

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour‐to‐tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation‐specific antibodies

By  

HISTOPATHOLOGY, Vol. 67, Iss. 2, 2015-08 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1001-1011

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography

By  

CLINICAL ENDOCRINOLOGY, Vol. 81, Iss. 3, 2014-09 ,pp. : 432-439

John Wiley & Sons Inc

Access to resources Recommend Favorite